Heilongjiang ZBD Pharmaceutical Co Ltd Total Liabilities

Latest as of March 2026: CN¥4.36 Billion CNY ≈ $638.27 Million USD

Heilongjiang ZBD Pharmaceutical Co Ltd total liabilities. Based on the latest financial reports, Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has total liabilities worth CN¥4.36 Billion CNY (≈ $638.27 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 603567 financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2025)

Total liabilities of Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2025. This chart illustrates how Heilongjiang ZBD Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore long-term investment intensity of Heilongjiang ZBD Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.

Heilongjiang ZBD Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Heilongjiang ZBD Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Steel Partners Holdings LP NYSE:SPLP	USA	$2.41 Billion
Tropicana Corporation Bhd KLSE:5401	Malaysia	RM6.00 Billion
MA Financial Group Ltd AU:MAF	Australia	AU$8.06 Billion
Shanghai Kinetic Medical Co SHE:300326	China	CN¥495.68 Million
Tianjin Jingwei Electric Wire Co Ltd SHE:300120	China	CN¥3.67 Billion
YIT Oyj HE:YIT	Finland	€1.59 Billion
CK Power Public Company Limited BK:CKP-R	Thailand	฿35.18 Billion
HMT Limited NSE:HMT	India	Rs24.87 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Heilongjiang ZBD Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 603567 total assets.

Liquidity & Leverage Metrics

Heilongjiang ZBD Pharmaceutical Co Ltd Total Liabilities Ratios Explained

Heilongjiang ZBD Pharmaceutical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.38	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.71	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.42	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Heilongjiang ZBD Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2025)

The table below shows the annual total liabilities of Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥4.36 Billion ≈ $637.29 Million	-1.50%
2024-12-31	CN¥4.42 Billion ≈ $647.01 Million	-0.08%
2023-12-31	CN¥4.43 Billion ≈ $647.55 Million	-3.14%
2022-12-31	CN¥4.57 Billion ≈ $668.53 Million	+2.55%
2021-12-31	CN¥4.45 Billion ≈ $651.89 Million	-5.84%
2020-12-31	CN¥4.73 Billion ≈ $692.32 Million	+25.55%
2019-12-31	CN¥3.77 Billion ≈ $551.45 Million	+17.81%
2018-12-31	CN¥3.20 Billion ≈ $468.06 Million	+44.94%
2017-12-31	CN¥2.21 Billion ≈ $322.94 Million	+4.48%
2016-12-31	CN¥2.11 Billion ≈ $309.10 Million	+7.33%
2015-12-31	CN¥1.97 Billion ≈ $288.00 Million	+37.49%
2014-12-31	CN¥1.43 Billion ≈ $209.47 Million	-4.83%
2013-12-31	CN¥1.50 Billion ≈ $220.09 Million	+86.07%
2012-12-31	CN¥808.30 Million ≈ $118.28 Million	+56.43%
2011-12-31	CN¥516.70 Million ≈ $75.61 Million	--

About Heilongjiang ZBD Pharmaceutical Co Ltd

SHG:603567 China Drug Manufacturers - Specialty & Generic

Market Cap

$689.31 Million

CN¥4.71 Billion CNY

Market Cap Rank

#10294 Global

#2721 in China

Share Price

CN¥5.01

Change (1 day)

-1.38%

52-Week Range

CN¥4.28 - CN¥11.70

All Time High

CN¥28.17